Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

Bone Marrow Transplant. 2020 Aug;55(8):1687-1689. doi: 10.1038/s41409-020-0785-9. Epub 2020 Jan 14.

Kathryn T Maples¹, Molly Maloy², Sean Devlin³, Andrew Lin⁴, Lauren DeRespiris⁴, Meagan Griffin⁴, Carmen Lau⁴, Anthony J Proli⁴, Genovefa A Papanicolaou^{2

5}, Susan K Seo^{2

5}, Juliet N Barker^{2

5}, Miguel-Angel Perales^{2

5}, Sergio A Giralt^{2

5}, Valkal Bhatt⁴

¹ Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kathryn.maples@gmail.com.
² Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

No abstract available

Publication types